Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 58,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Mr. Rainer Blair est le President de Danaher Corp, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action DHR ?
Le prix actuel de DHR est de $188.9, il a diminué de 0.57% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Danaher Corp ?
Danaher Corp appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quel est la capitalisation boursière de Danaher Corp ?
La capitalisation boursière actuelle de Danaher Corp est de $133.5B
Est-ce que Danaher Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 24 analystes ont établi des notations d'analystes pour Danaher Corp, y compris 12 achat fort, 15 achat, 4 maintien, 0 vente et 12 vente forte